GE Medical Systems Ultrasound and Primary Care Diagnostics · Class II · Cleared Jul 10, 2025
| K-number | K251169 |
| Device name | Vivid Pioneer |
| Applicant | GE Medical Systems Ultrasound and Primary Care Diagnostics |
| Product code | IYN |
| Device class | Class II |
| Decision date | Jul 10, 2025 |
| Decision | Substantially Equivalent |
| Regulation | 892.1550 |
The Vivid Pioneer is a mobile, general-purpose diagnostic ultrasound system primarily designed for cardiac imaging but also supporting vascular and general radiology applications. It provides digital acquisition, processing, display and analysis of ultrasound images across numerous clinical settings including hospitals and private medical offices. The system includes electronic array transducers, a touchscreen interface, and can perform multiple imaging modes including 2D, 3D, Doppler, and color flow imaging.
The Vivid Pioneer employs the same fundamental ultrasound technology as its predicate Vivid E95. Key differences include: addition of a new 6Sc-D transducer with identical indications and modes as the predicate 6S-D; multiple new or enhanced software features including AI Cardiac Auto Doppler, AI FlexiViews LAA, cSound Pioneer imaging reconstruction, and Clarity+ filtering; and support for new accessories including wireless adapters and compatibility with CARTO 3 navigation systems and Nuvision NAV catheters.
The device was evaluated against AAMI/ANSI ES60601-1, IEC 60601-1-2, IEC 60601-2-37, ISO 10993-1, ISO 14971, NEMA PS 3.1-3.20 (DICOM), and IEC 62359. Testing covered acoustic output, biocompatibility, cleaning/disinfection, thermal, electrical, electromagnetic and mechanical safety. The AI algorithms (Tissue Doppler and Doppler Trace) were verified against datasets of 4,106 and 3,390 recordings respectively across multiple demographics and equipment configurations.
The Vivid Pioneer is substantially equivalent to the Vivid E95 because it maintains identical clinical indications for use, employs the same fundamental ultrasound technology, and demonstrates conformance to the same recognized safety and performance standards. The new software features and transducers represent incremental enhancements built on predicate tools already cleared with the Vivid E95 (e.g., AI Doppler combines existing auto-tracing with additional measurements; new imaging modes enhance existing visualization techniques). Performance testing of the AI algorithms demonstrates accuracy comparable to clinical expert measurements across diverse patient populations and equipment configurations.
View the full FDA submission: accessdata.fda.gov